首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
【24h】

Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.

机译:基于药物的物理状态,粒度分布和药物-聚合物相互作用,研究了微水溶性药物从亲水性载体中的固体分散体释放的机理。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study the release mechanism of the sparingly water-soluble drug felodipine (FELO) from particulate solid dispersions in PVP or PEG was investigated. FT-IR data indicated that a N-H...O hydrogen bond is formed between FELO and polymers. The drug-polymer interaction was theoretically studied with the density functional theory with the B3LYP exchange correlation function. The interaction energies have been estimated at -31.8 kJ/mol for PVP and -18.8 kJ/mol for PEG. Also, detailed vibrational analysis of the complexes showed that the red shift of the N-H bond stretching in FELO molecule due to H-bonding was higher in the FELO-PVP complex than in the FELO-PEG complex. Both the experimental and theoretical data indicated that a stronger interaction of FELO with PVP than with PEG was developed. The interactions of FELO with the polymer appeared to control the physical state (amorphous or crystalline) and the particle size of FELO in the solid dispersions. In the FELO/PVP dispersions, the drug is found as amorphous nanoparticles whereas in FELO/PEG dispersions the drug is dispersed as crystalline microparticles. The size of drug particles in the dispersion was also influenced by drug proportion, with an increase in drug content of the dispersion resulting in increased drug particle size. The particle size of drug, the proportion of drug in the dispersion and the properties of the polymer (molecular weight) appeared to determine the mechanism of drug release from the solid dispersions, which was drug diffusion (through the polymer layer)-controlled at low drug contents and drug dissolution-controlled at high drug contents. In situ DLS measurements indicate that the large initial particles of FELO/PVP and FELO/PEG solid dispersions with low drug content (10-20 wt%) are very rapidly decreased to smaller particles (including nanoparticles) during dissolution, leading to the observed impressive enhancement of FELO release rate from these dispersions.
机译:在本研究中,研究了微水溶性药物非洛地平(FELO)从PVP或PEG中的颗粒状固体分散体中的释放机理。 FT-IR数据表明在FELO和聚合物之间形成了N-H ... O氢键。用具有B3LYP交换相关函数的密度泛函理论对药物-聚合物的相互作用进行了理论研究。对于PVP,相互作用能估计为-31.8 kJ / mol,对于PEG,相互作用能为-18.8 kJ / mol。而且,对配合物的详细振动分析表明,FELO-PVP配合物中比HLO键高的FELO分子中由于H键引起的N-H键延伸的红移高于FELO-PEG配合物中。实验和理论数据均表明,FELO与PVP的相互作用比与PEG的相互作用更强。 FELO与聚合物的相互作用似乎可以控制固体分散体中FELO的物理状态(无定形或晶体)和粒径。在FELO / PVP分散液中,该药物为无定形纳米粒子,而在FELO / PEG分散液中,该药物为结晶性微粒。分散体中药物颗粒的尺寸也受药物比例的影响,分散体中药物含量的增加导致药物颗粒尺寸的增加。药物的粒径,分散体中药物的比例以及聚合物的性质(分子量)似乎决定了药物从固体分散体中释放的机理,这是将药物扩散(通过聚合物层)控制在较低的水平药物含量和药物溶解控制在高药物含量下。原位DLS测量表明,在溶解过程中,具有低药物含量(10-20 wt%)的FELO / PVP和FELO / PEG固体分散体的较大初始颗粒非常迅速地减少为较小的颗粒(包括纳米颗粒),从而观察到令人印象深刻这些分散体的FELO释放速率提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号